Compare

Chemomab Therapeutics Ltd. vs CytoDyn Inc. vs Actuate Therapeutics, Inc. vs CalciMedica, Inc.

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal year	Chemomab Therapeutics Ltd. CMMB	CytoDyn Inc. CYDY	Actuate Therapeutics, Inc. ACTU	CalciMedica, Inc. CALC
Year ended	2025-12-31	2026-05-31	2025-12-31	2025-12-31
Revenue	n/a	n/a	n/a	n/a
Revenue growth (YoY)	n/a	n/a	n/a	n/a
Gross margin	n/a	n/a	n/a	n/a
Operating margin	n/a	n/a	n/a	n/a
Net margin	n/a	n/a	n/a	n/a
Net income	-$8.99M	-$42.70M	-$22.23M	-$29.56M
EPS (Diluted)	$0.018	-$0.03	-$1.06	-$1.97
Operating cash flow	-$11.13M	-$17.25M	-$19.21M	-$21.18M
Free cash flow	-$11.13M	n/a	n/a	-$21.21M
Cash & equivalents	$7.56M	$11.85M	$13.16M	$11.52M
Total assets	$13.81M	$13.97M	$14.04M	$13.59M
Total liabilities	$1.48M	$123.69M	$6.11M	$20.23M
Shareholders' equity	$12.33M	-$109.72M	$7.92M	-$6.64M
Return on year-end equity	-72.9%	n/a	-280.5%	n/a
Shares outstanding	n/a	1.37B	23.25M	15.44M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal year	Chemomab Therapeutics Ltd.	CytoDyn Inc.	Actuate Therapeutics, Inc.	CalciMedica, Inc.
Latest	n/a	$0 Ended 2023-05-31	n/a	n/a
1 year earlier	n/a	$266.0K Ended 2022-05-31	n/a	n/a
2 years earlier	n/a	$0 Ended 2021-05-31	n/a	n/a
3 years earlier	n/a	n/a	n/a	n/a
4 years earlier	n/a	n/a	n/a	n/a